-       Report 
   - August 2025
    -  192 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2422EUR$2,699USD£2,126GBP 
                  -       Report 
   - September 2025
    -  140 Pages 
    Global
   
   From       €3699EUR$4,123USD£3,247GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - July 2025
    -  267 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                   -       Report 
   - May 2024
    -  130 Pages 
    Global
   
   From       €4957EUR$5,524USD£4,351GBP 
      €5832EUR$6,499USD£5,118GBP 
                -       Report 
   - January 2024
    -  78 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - January 2024
    -  113 Pages 
    United States
   
        €3141EUR$3,500USD£2,756GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2378EUR$2,650USD£2,087GBP 
                      Calcitriol is a type of psoriasis drug used to treat moderate to severe plaque psoriasis. It is a synthetic form of vitamin D3, which helps to reduce inflammation and slow the growth of skin cells. Calcitriol is available in both topical and oral forms, and is often used in combination with other psoriasis treatments. It is generally well-tolerated, but can cause side effects such as skin irritation, itching, and redness.
The calcitriol market is a growing segment of the psoriasis drug market. It    is used to treat a wide range of psoriasis symptoms, from mild to severe. It is also used to treat other skin conditions, such as eczema and acne. As the prevalence of psoriasis increases, the demand for calcitriol is expected to rise.
Some companies in the calcitriol market include AbbVie, Amgen, and Novartis. Other companies include Celgene, Janssen, and Sun Pharmaceuticals. Show Less   Read more